Abstract
It is the purpose of this chapter to review the actual understanding of the pathophysiology of chronically dysfunctional but viable myocardium and its implications for detection of myocardial viability using echocardiography but also to discuss the clinical role of myocardial viability at present time.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Vanoverschelde J-LJ, Wijns W, Depré C, Essamri B, Heyndrickx G, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of non-infarcted collateral dependent myocardium. Circulation. 1993;87:1513–23.
Vanoverschelde J-LJ, Wijns W, Borgers M, Heyndrickx G, Depré C, Flameng W, Melin JA. Chronic myocardial hibernation in humans. From bedside to bench. Circulation. 1997;95:1961–71.
Ross J Jr. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation. Circulation. 1991;83:1076–83.
Canty JR, Fallavollita JA. Resting myocardial flow in hibernating myocardium: validating animal models of human pathophysiology. Am J Physiol. 1999;277:H417–22.
Borgers M, Thoné F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol. 1993;2:237–45.
Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease. J Am Coll Cardiol. 1997;30:1451–60.
Selvanayagam JB, Jerosch-Herold M, Porto I, et al. Resting myocardial blood flow is impaired in hibernating myocardium: a magnetic resonance study of quantitative perfusion assessment. Circulation. 2005;112:3289–96.
Rahimtoola SH, Dilsizian V, Kramer Ch M, Marwick TH, Vanoverschelde J-LJ, from picture to practice paradigms. Chronic ischemic left ventricular dysfunction: from pathophysiology to imaging and its integration into clinical practice. JACC Cardiovasc Imaging. 2008;1:536–55.
Bayeva M, Sawicki KT, Bultler J, Gheorghiade M, Ardehali H. Molecular and cellular basis of viable dysfunctional myocardium. Circ Heart Fail. 2014;7:680–91.
Schinkel AFL, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32:375–410.
Anavekar N, Chareonthaitawee P, Narula J, Gersh B. Revascularization in patients with severe left ventricular dysfunction. Is the assessment of viability still viable? J Am Coll Cardiol. 2016;67:2874–87.
Montant P, Chenot F, Goffinet C, Poncelet A, Vancraeynest D, Pasquet A, Gerber BL, Vanoverschelde J-LJ. Detection and quantification of myocardial scars by contrast-enhanced 3D echocardiography. Circ Cardiovasc Imaging. 2010;3:415–23.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a metaanalysis. J Am Coll Cardiol. 2002;39:1151–8.
Cleland JGF, Pennell DJ, Ray SG, CHRISTMAS (Carvedilol Hibernating Reversible Ischaemia Trial: Marker of Success) Investigators, et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomized controlled trial. Lancet. 2003;362:14–21.
Beanlands RSB, Nichol G, Huszti E, PARR-2 Investigators, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50:2002–12.
D’Egidio G, Nichol G, Williams KA, PARR-2 Investigators, et al. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. J Am Coll Cardiol Img. 2009;2:1060–8.
Bonow RO, Maurer G, Lee KL, STICH Trial Investigators, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Pasquet, A., Gerber, B., Vanoverschelde, JL.J. (2018). Assessing Myocardial Viability: Principles and the Role of Echocardiography. In: Nihoyannopoulos, P., Kisslo, J. (eds) Echocardiography. Springer, Cham. https://doi.org/10.1007/978-3-319-71617-6_22
Download citation
DOI: https://doi.org/10.1007/978-3-319-71617-6_22
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71615-2
Online ISBN: 978-3-319-71617-6
eBook Packages: MedicineMedicine (R0)